We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Column Group
California
$304M
RCP
2
Rho Capital Partners
New York
$74.3M
RG
3
Redmile Group
California
$55.1M +$951K +40,633 +1%
BlackRock
4
BlackRock
New York
$45.3M -$10.9M -465,225 -17%
GA
5
Greenspring Associates
Maryland
$31M
EC
6
Euclidean Capital
New York
$29.4M
Vanguard Group
7
Vanguard Group
Pennsylvania
$27.4M -$20M -852,374 -38%
PIM
8
Ponoi II Management
California
$25.6M
PM
9
Ponoi Management
California
$25.6M
ACM
10
Aquilo Capital Management
California
$23.6M +$1.64M +70,000 +6%
BI
11
BVF Inc
California
$18.8M +$22.4M +955,000 New
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$17M -$30.7M -1,310,800 -60%
Citadel Advisors
13
Citadel Advisors
Florida
$14M +$7.67M +327,650 +86%
JP Morgan Chase
14
JP Morgan Chase
New York
$12.1M +$10.2M +437,541 +250%
State Street
15
State Street
Massachusetts
$11.7M +$2.5M +106,936 +22%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$11.4M +$2.75M +117,483 +26%
CS
17
Candriam SCA
Luxembourg
$11.1M +$8.01M +342,425 +155%
BC
18
Boxer Capital
California
$9.86M +$11.7M +500,000 New
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$8.56M +$1.27M +54,395 +14%
JRP
20
Jasper Ridge Partners
California
$6.12M +$35.1K +1,500 +0.5%
Northern Trust
21
Northern Trust
Illinois
$5.87M +$552K +23,600 +9%
Axa
22
Axa
France
$5.77M +$6.84M +292,441 New
BBA
23
Baker Bros. Advisors
New York
$5.75M
HWAM
24
Hennion & Walsh Asset Management
New Jersey
$5.65M +$623K +26,617 +10%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$4.99M +$523K +22,351 +10%